Rakovina Therapeutics (TSXV:RKV) Total Operating Expense : C$3.05 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rakovina Therapeutics Total Operating Expense?

Rakovina Therapeutics's Total Operating Expense for the three months ended in Sep. 2024 was C$0.95 Mil. Rakovina Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was C$3.05 Mil.

Rakovina Therapeutics Total Operating Expense Historical Data

The historical data trend for Rakovina Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics Total Operating Expense Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Total Operating Expense

2.47

2.82

2.48

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Operating Expense	Get a 7-Day Free Trial										0.59	0.66	0.69	0.76	0.95

Rakovina Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3.05 Mil.

Rakovina Therapeutics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (TSXV:RKV) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

RKVTF:USA 7JO:Germany

Address

595 Burrard Street, P.O. Box 49314, Suite 2600, Three Bentall Centre, Vancouver, BC, CAN, V6B 0A5

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some of its products in the pipeline include kt-2000 AI, kt-3000 series. Rakovina gained exclusive use of the Deep Docking AI Platform, enabling it to significantly speed up identifying potential drugs for DNA damage response.

Executives

Jeffrey Bacha	Senior Officer
Alfredo De Lucrezia	Director, Senior Officer
Michael Liggett	Director
Mads Daugaard	Senior Officer
David Hyman	Senior Officer
John Michael Langlands	Senior Officer

Rakovina Therapeutics Headlines

No Headlines